C2 PHARMA is the global leader in ophthalmic active pharmaceutical ingredients (APIs). Founded in 2014 and headquartered in Cork, Ireland, C2 PHARMA manufactures and distributes APls and complex chemical compounds obtained from synthetic and natural origins, ensuring a reliable supply of high-quality APIs at competitive prices. With our current API product portfolio, we reach more than 200 pharmaceutical companies across the United States, Western and Eastern Europe, South America, Asia, the Middle East, and Africa. C² PHARMA is a key sponsor of the “Partnership for a Better World” program that ensures a sustainable, traceable & fair-trade harvesting and sourcing of phytochemicals and botanicals used for pharmaceutical APIs such as Pilocarpine. The program sustains more than 1,000 families and contributes to preserving Brazilian biodiversity. #c2Pharma; #C²Pharma; #c2 Pharma; #C² Pharma; #Centroflora CMS
Looking for a particular Centroflora CMS employee's phone or email?
Centroflora CMS Questions
The Centroflora CMS annual revenue was $5.4 million in 2026.
Katrien Oosterom is the Vice President of Regulatory Affairs of Centroflora CMS.
18 people are employed at Centroflora CMS.
The NAICS codes for Centroflora CMS are [32541, 32, 3254, 325].
The SIC codes for Centroflora CMS are [283, 2834, 28].
Top Centroflora CMS Employees
